BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34636637)

  • 1. Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.
    Prescott JW; Doraiswamy PM; Gamberger D; Benzinger T; Petrella JR;
    Radiology; 2022 Jan; 302(1):143-150. PubMed ID: 34636637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
    Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
    JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
    Boerwinkle AH; Gordon BA; Wisch J; Flores S; Henson RL; Butt OH; McKay N; Chen CD; Benzinger TLS; Fagan AM; Handen BL; Christian BT; Head E; Mapstone M; Rafii MS; O'Bryant S; Lai F; Rosas HD; Lee JH; Silverman W; Brickman AM; Chhatwal JP; Cruchaga C; Perrin RJ; Xiong C; Hassenstab J; McDade E; Bateman RJ; Ances BM; ;
    Lancet Neurol; 2023 Jan; 22(1):55-65. PubMed ID: 36517172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease.
    Smith RX; Strain JF; Tanenbaum A; Fagan AM; Hassenstab J; McDade E; Schindler SE; Gordon BA; Xiong C; Chhatwal J; Jack C; Karch C; Berman S; Brosch JR; Lah JJ; Brickman AM; Cash DM; Fox NC; Graff-Radford NR; Levin J; Noble J; Holtzman DM; Masters CL; Farlow MR; Laske C; Schofield PR; Marcus DS; Morris JC; Benzinger TLS; Bateman RJ; Ances BM
    Brain Connect; 2021 Apr; 11(3):239-249. PubMed ID: 33430685
    [No Abstract]   [Full Text] [Related]  

  • 5. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Positron Emission Tomography Amyloid Pathology and Diffusion Tensor Imaging Brain Connectivity in Pre-Clinical Alzheimer's Disease.
    Hwang SJ; Adluru N; Kim WH; Johnson SC; Bendlin BB; Singh V
    Brain Connect; 2019 Mar; 9(2):162-173. PubMed ID: 30255713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
    Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
    Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired default network functional connectivity in autosomal dominant Alzheimer disease.
    Chhatwal JP; Schultz AP; Johnson K; Benzinger TL; Jack C; Ances BM; Sullivan CA; Salloway SP; Ringman JM; Koeppe RA; Marcus DS; Thompson P; Saykin AJ; Correia S; Schofield PR; Rowe CC; Fox NC; Brickman AM; Mayeux R; McDade E; Bateman R; Fagan AM; Goate AM; Xiong C; Buckles VD; Morris JC; Sperling RA
    Neurology; 2013 Aug; 81(8):736-44. PubMed ID: 23884042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease.
    Millar PR; Gordon BA; Wisch JK; Schultz SA; Benzinger TL; Cruchaga C; Hassenstab JJ; Ibanez L; Karch C; Llibre-Guerra JJ; Morris JC; Perrin RJ; Supnet-Bell C; Xiong C; Allegri RF; Berman SB; Chhatwal JP; Chrem Mendez PA; Day GS; Hofmann A; Ikeuchi T; Jucker M; Lee JH; Levin J; Lopera F; Niimi Y; Sánchez-González VJ; Schofield PR; Sosa-Ortiz AL; Vöglein J; ; Bateman RJ; Ances BM; McDade EM
    Mol Neurodegener; 2023 Dec; 18(1):98. PubMed ID: 38111006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease.
    Dincer A; Gordon BA; Hari-Raj A; Keefe SJ; Flores S; McKay NS; Paulick AM; Shady Lewis KE; Feldman RL; Hornbeck RC; Allegri R; Ances BM; Berman SB; Brickman AM; Brooks WS; Cash DM; Chhatwal JP; Farlow MR; la Fougère C; Fox NC; Fulham MJ; Jack CR; Joseph-Mathurin N; Karch CM; Lee A; Levin J; Masters CL; McDade EM; Oh H; Perrin RJ; Raji C; Salloway SP; Schofield PR; Su Y; Villemagne VL; Wang Q; Weiner MW; Xiong C; Yakushev I; Morris JC; Bateman RJ; L S Benzinger T;
    Neuroimage Clin; 2020; 28():102491. PubMed ID: 33395982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.
    Prescott JW; Guidon A; Doraiswamy PM; Roy Choudhury K; Liu C; Petrella JR;
    Radiology; 2014 Oct; 273(1):175-84. PubMed ID: 24865310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer's disease: findings from the Colombia-Boston (COLBOS) biomarker study.
    Sanchez JS; Hanseeuw BJ; Lopera F; Sperling RA; Baena A; Bocanegra Y; Aguillon D; Guzmán-Vélez E; Pardilla-Delgado E; Ramirez-Gomez L; Vila-Castelar C; Martinez JE; Fox-Fuller JT; Ramos C; Ochoa-Escudero M; Alvarez S; Jacobs HIL; Schultz AP; Gatchel JR; Becker JA; Katz SR; Mayblyum DV; Price JC; Reiman EM; Johnson KA; Quiroz YT
    Alzheimers Res Ther; 2021 Jan; 13(1):27. PubMed ID: 33451357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer's disease.
    Hampton OL; Buckley RF; Manning LK; Scott MR; Properzi MJ; Peña-Gómez C; Jacobs HIL; Chhatwal JP; Johnson KA; Sperling RA; Schultz AP
    Neuroimage Clin; 2020; 28():102407. PubMed ID: 32942175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.
    Lee S; Viqar F; Zimmerman ME; Narkhede A; Tosto G; Benzinger TL; Marcus DS; Fagan AM; Goate A; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Ryan NS; Förster S; Laske C; Schofield PR; Sperling RA; Salloway S; Correia S; Jack C; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
    Ann Neurol; 2016 Jun; 79(6):929-39. PubMed ID: 27016429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional amyloid burden and intrinsic connectivity networks in cognitively normal elderly subjects.
    Lim HK; Nebes R; Snitz B; Cohen A; Mathis C; Price J; Weissfeld L; Klunk W; Aizenstein HJ
    Brain; 2014 Dec; 137(Pt 12):3327-38. PubMed ID: 25266592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MRI Delivers Multimodal Brain Signature in Alzheimer's Disease with De Novo PSEN1 Mutation.
    Aghakhanyan G; Saur D; Rullmann M; Weise CM; Schroeter ML; Marek K; Jamra RA; Tiepolt S; Strauss M; Scherlach C; Hoffmann KT; Sabri O; Classen J; Barthel H
    Curr Alzheimer Res; 2021; 18(2):178-184. PubMed ID: 33855944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
    Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
    JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging biomarkers in preclinical autosomal dominant Alzheimer's disease by estimated years to symptom onset.
    Wang G; Coble D; McDade EM; Hassenstab J; Fagan AM; Benzinger TLS; Bateman RJ; Morris JC; Xiong C;
    Alzheimers Dement; 2019 Apr; 15(4):506-514. PubMed ID: 30773445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.